Qibin Su

1.0k total citations
21 papers, 722 citations indexed

About

Qibin Su is a scholar working on Oncology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Qibin Su has authored 21 papers receiving a total of 722 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Organic Chemistry and 8 papers in Molecular Biology. Recurrent topics in Qibin Su's work include Synthetic Organic Chemistry Methods (7 papers), Cytokine Signaling Pathways and Interactions (7 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). Qibin Su is often cited by papers focused on Synthetic Organic Chemistry Methods (7 papers), Cytokine Signaling Pathways and Interactions (7 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). Qibin Su collaborates with scholars based in United States, United Kingdom and Sweden. Qibin Su's co-authors include James S. Panek, Neil P. Grimster, Claudio Chuaqui, Les A. Dakin, Alexander W. Hird, Brian Aquila, Nancy Su, Michelle L. Lamb, Philip B. Rawlins and Matthew A. Belmonte and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Cancer Research.

In The Last Decade

Qibin Su

20 papers receiving 710 citations

Peers

Qibin Su
John I. Trujillo United States
Shohei Shirakami Japan
Anne Mengel Germany
Jagabandhu Das United States
Jeffrey B. Epp United States
Ted L. Underiner United States
Kristi Leonard United States
Rainer Metternich Switzerland
Edwin J. Iwanowicz United States
Kevin Blades United Kingdom
John I. Trujillo United States
Qibin Su
Citations per year, relative to Qibin Su Qibin Su (= 1×) peers John I. Trujillo

Countries citing papers authored by Qibin Su

Since Specialization
Citations

This map shows the geographic impact of Qibin Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qibin Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qibin Su more than expected).

Fields of papers citing papers by Qibin Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qibin Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qibin Su. The network helps show where Qibin Su may publish in the future.

Co-authorship network of co-authors of Qibin Su

This figure shows the co-authorship network connecting the top 25 collaborators of Qibin Su. A scholar is included among the top collaborators of Qibin Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qibin Su. Qibin Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berggren, Kristina, Silvia Cerboni, Göran Dahl, et al.. (2023). Discovery of the Potent and Selective Inhaled Janus Kinase 1 Inhibitor AZD4604 and Its Preclinical Characterization. Journal of Medicinal Chemistry. 66(19). 13400–13415. 8 indexed citations
2.
Barlaam, Bernard, Scott Boiko, Scott Boyd, et al.. (2020). Novel potent and selective pyrazolylpyrimidine-based SYK inhibitors. Bioorganic & Medicinal Chemistry Letters. 30(22). 127523–127523. 3 indexed citations
3.
Yang, Bin, Melissa M. Vasbinder, Alexander W. Hird, et al.. (2018). Adventures in Scaffold Morphing: Discovery of Fused Ring Heterocyclic Checkpoint Kinase 1 (CHK1) Inhibitors. Journal of Medicinal Chemistry. 61(3). 1061–1073. 20 indexed citations
4.
Kettle, Jason G., Qibin Su, Neil P. Grimster, et al.. (2017). Abstract 979: Discovery of the JAK1 selective kinase inhibitor AZD4205. Cancer Research. 77(13_Supplement). 979–979. 5 indexed citations
5.
Belmonte, Matthew A., Brian Aquila, Claudio Chuaqui, et al.. (2016). Inhibition of Mcl-1 through covalent modification of a noncatalytic lysine side chain. Nature Chemical Biology. 12(11). 931–936. 162 indexed citations
6.
Kettle, Jason G., Annika Åstrand, Matthew C. Catley, et al.. (2016). Inhibitors of JAK-family kinases: an update on the patent literature 2013-2015, part 2. Expert Opinion on Therapeutic Patents. 27(2). 145–161. 14 indexed citations
7.
Kettle, Jason G., Annika Åstrand, Matthew C. Catley, et al.. (2016). Inhibitors of JAK-family kinases: an update on the patent literature 2013-2015, part 1. Expert Opinion on Therapeutic Patents. 27(2). 127–143. 22 indexed citations
8.
Hennessy, Edward J., Gurmit Grewal, Kate F. Byth, et al.. (2015). Discovery of heterocyclic sulfonamides as sphingosine 1-phosphate receptor 1 (S1P1) antagonists. Bioorganic & Medicinal Chemistry Letters. 25(10). 2041–2045. 2 indexed citations
9.
Hennessy, Edward J., Vibha Oza, Ammar Adam, et al.. (2015). Identification and Optimization of Benzimidazole Sulfonamides as Orally Bioavailable Sphingosine 1-Phosphate Receptor 1 Antagonists with in Vivo Activity. Journal of Medicinal Chemistry. 58(17). 7057–7075. 19 indexed citations
10.
Woessner, Richard, Geraldine Bebernitz, Kirsten Bell, et al.. (2013). Abstract 931: Highly selective JAK1 kinase inhibitors suppress Y705-mediated STAT3 activation in a wide range of tumor types, with reduced hematological toxicity.. Cancer Research. 73(8_Supplement). 931–931.
11.
Yang, Bin, Alexander W. Hird, Daniel Russell, et al.. (2012). Discovery of novel hedgehog antagonists from cell-based screening: Isosteric modification of p38 bisamides as potent inhibitors of SMO. Bioorganic & Medicinal Chemistry Letters. 22(14). 4907–4911. 15 indexed citations
12.
Wang, Tao, Scott D. Cowen, Audrey M. Davies, et al.. (2012). Discovery of azabenzimidazole derivatives as potent, selective inhibitors of TBK1/IKKε kinases. Bioorganic & Medicinal Chemistry Letters. 22(5). 2063–2069. 38 indexed citations
13.
Su, Qibin, Les A. Dakin, & James S. Panek. (2006). [4 + 2]-Annulations of Chiral Organosilanes:  Application to the Total Synthesis of Leucascandrolide A. The Journal of Organic Chemistry. 72(1). 2–24. 60 indexed citations
14.
Su, Qibin & James S. Panek. (2005). Total Synthesis of (+)‐Leucascandrolide A. Angewandte Chemie International Edition. 44(8). 1223–1225. 46 indexed citations
15.
Su, Qibin & James S. Panek. (2005). Total Synthesis of (+)‐Leucascandrolide A. Angewandte Chemie. 117(8). 1249–1251. 9 indexed citations
16.
Beeler, Aaron B., Qibin Su, Feng Yan, et al.. (2005). Synthesis of a Library of Complex Macrodiolides Employing Cyclodimerization of Hydroxy Esters. Journal of Combinatorial Chemistry. 7(5). 673–681. 39 indexed citations
17.
Kesavan, Sarathy, Qibin Su, Jian Q. Shao, John A. Porco, & James S. Panek. (2005). Enantioselective Synthesis of Linear Polypropionate Arrays Using Anthracene-Tagged Organosilanes. Organic Letters. 7(20). 4435–4438. 10 indexed citations
18.
Su, Qibin & James S. Panek. (2004). Total Synthesis of (−)-Apicularen A. Journal of the American Chemical Society. 126(8). 2425–2430. 112 indexed citations
19.
Su, Qibin, Aaron B. Beeler, Emil B. Lobkovsky, John A. Porco, & James S. Panek. (2003). Stereochemical Diversity through Cyclodimerization:  Synthesis of Polyketide-like Macrodiolides. Organic Letters. 5(12). 2149–2152. 48 indexed citations
20.
Zhang, Yugen, Jianmin Li, Jinhua Chen, et al.. (2000). A Novel α-Helix-Liked Metallohelicate Series and Their Structural Adjustments for the Isomorphous Substitution. Inorganic Chemistry. 39(11). 2330–2336. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John I. Trujillo Breakdown of academic impact, for papers by Shohei Shirakami Breakdown of academic impact, for papers by Anne Mengel Breakdown of academic impact, for papers by Jagabandhu Das Breakdown of academic impact, for papers by Jeffrey B. Epp Breakdown of academic impact, for papers by Ted L. Underiner Breakdown of academic impact, for papers by Kristi Leonard Breakdown of academic impact, for papers by Rainer Metternich Breakdown of academic impact, for papers by Edwin J. Iwanowicz Breakdown of academic impact, for papers by Kevin Blades
Rankless by CCL
2026